Company profile
ForU Holdings, Inc.
OTC: FORU · Healthcare · Biotechnology
#1163 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 39
v0.1 · 5/100 weight · pillars only
↑ listing tenure, Altman-Z · ↓ 3-yr revenue growth, Piotroski F
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
-100.0%
Net income (FY)
-$16.0M
Employees
7
as of 2026-08-31
Market cap
$4.3k
as of 2026-08-31
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$0$02010
Net income-$16.0M-$16.0M2010
Operating income-$13.1M-$13.1M2010
Total assets$4.5M$4.5M2010
Liabilities$7.2M$7.2M2010
Equity-$2.6M-$2.6M2010
Revenue trend
FY2007 – FY2010 · USD
FY07
FY08
FY09
FY10
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is ForU Holdings, Inc.’s revenue?
ForU Holdings, Inc. booked $0 in FY2010 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
Bio-Path Holdings, Inc.——Life Stem Genetics Inc.——Innovation1 Biotech Inc.——Xeno Transplants Corporation——Claritas Pharmaceuticals, Inc.——Rapid Therapeutic Science Laboratories, Inc.——Neighbors
Cook →Key facts
CEODavid Elliot Lazar
SectorHealthcare
IndustryBiotechnology
HeadquartersBarrington, IL
ExchangeOTC: FORU
Employees7
IPO date1999-12-23
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.